Aoi Ohnuma

Aoi Ohnuma

Auto-generated profile, based on publicly available information

Aoi Ohnuma

Genetic Analysis Department Laboratory of Racing Chemistry Utsunomiya Tochigi Japan

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2019 in Genes
Verified
Journal Article
Open access
PDF file
Teruaki TozakiTeruaki Tozaki
Teruaki Tozaki
AOAoi Ohnuma
Aoi Ohnuma
MTMasaki Takasu
Masaki Takasu
MKMIO KIKUCHI
MIO KIKUCHI
HKHironaga Kakoi
Hironaga Kakoi
SNShun-Ichi Nagata
Shun-Ichi Nagata
Indiscriminate genetic manipulation to improve athletic ability is a major threat to human sports and the horseracing industry, in which methods involving gene-doping, such as transgenesis, should be prohibited to ensure fairness. Therefore, development of methods to detect indiscriminate genetic manipulation are urgently needed. Here, we developed a highly sensitive method to detect horse erythropoietin (EPO) transgenes using droplet digital PCR (ddPCR). We designed two TaqMan probe/primer sets, and the EPO transgene was cloned into a plasmid for use as a model. We extracted the spiked EPO transgene from horse plasma and urine via magnetic beads, followed by ddPCR amplification for absolute quantification and transgene detection. The results indicated high recovery rates (at least ~60% and ~40% in plasma and urine, respectively), suggesting successful detection of the spiked transgene at concentrations of >130 and 200 copies/mL of plasma and urine, respectively. Additionally, successful detection was achieved following intramuscular injection of 20 mg of the EPO transgene. This represents the first study demonstrating a method for detecting the EPO transgene in horse plasma and urine, with our results demonstrating its efficacy for promoting the control of gene-doping in the horseracing industry.

23 April 2020 in Genes
Verified
Journal Article
Open access
PDF file
Teruaki TozakiTeruaki Tozaki
Teruaki Tozaki
AOAoi Ohnuma
Aoi Ohnuma
MKMIO KIKUCHI
MIO KIKUCHI
TITaichiro Ishige
Taichiro Ishige
HKHironaga Kakoi
Hironaga Kakoi
SNShun-Ichi Nagata
Shun-Ichi Nagata
Gene doping, an activity which abuses and misuses gene therapy, is a major concern in sports and horseracing industries. Effective methods capable of detecting and monitoring gene doping are urgently needed. Although several PCR-based methods that detect transgenes have been developed, many of them focus only on a single transgene. However, numerous genes associated with athletic ability may be potential gene-doping material. Here, we developed a detection method that targets multiple transgenes. We targeted 12 genes that may be associated with athletic performance and designed two TaqMan probe/primer sets for each one. A panel of 24 assays was prepared and detected via a microfluidic quantitative PCR (MFQPCR) system using integrated fluidic circuits (IFCs). The limit of detection of the panel was 6.25 copy/μL. Amplification-specificity was validated using several concentrations of reference materials and animal genomic DNA, leading to specific detection. In addition, target-specific detection was successfully achieved in a horse administered 20 mg of the EPO transgene via MFQPCR. Therefore, MFQPCR may be considered a suitable method for multiple-target detection in gene-doping control. To our knowledge, this is the first application of microfluidic qPCR (MFQPCR) for gene-doping control in horseracing.

1 August 2021 in Cell Reports
Verified
Journal Article
Open access
STShinya Takahata
Shinya Takahata
SCSaori Chida
Saori Chida
AOAoi Ohnuma
Aoi Ohnuma
MAMotoyoshi Ando
Motoyoshi Ando
TATakahiro Asanuma
Takahiro Asanuma
YMYota Murakami
Yota Murakami
FACT (facilitate chromatin transcription) is involved in heterochromatic silencing, but its mechanisms and function remain unclear. We reveal that the Spt16 recruitment mechanism operates in two distinct ways in heterochromatin. First, Pob3 mediates Spt16 recruitment onto the heterochromatin through its Spt16 dimerization and tandem PH domains. Without Pob3, Spt16 recruitment is partially reduced, exhibiting a silencing defect and impaired H2A/H2B organization. Second, heterochromatin protein 1 (HP1)/Swi6 mediates Spt16 recruitment onto the heterochromatin by physical interaction of the Swi6 chromo-shadow domain (CSD) and Spt16 peptidase-like domains. Several CSD mutants are tested for Spt16 binding activity, and the charged loop connecting β1 and β2 is critical for Spt16 binding and heterochromatic silencing. Loss of these pathways causes a severe defect in H3K9 methylation and HP1/Swi6 localization in the pericentromeric region, exhibiting transcriptional silencing defects and disordered heterochromatin. Our findings suggest that FACT and HP1/Swi6 work intimately to regulate heterochromatin organization.

7 August 2020 in Gene Therapy
Verified
Journal Article
Closed access
PDF file
Teruaki TozakiTeruaki Tozaki
Teruaki Tozaki
AOAoi Ohnuma
Aoi Ohnuma
MTMasaki Takasu
Masaki Takasu
KNKotono Nakamura
Kotono Nakamura
MKMio Kikuchi
Mio Kikuchi
SNShun-Ichi Nagata
Shun-Ichi Nagata

4 October 2021 in Drug Testing and Analysis
Verified
Journal Article
Closed access
PDF file
Teruaki TozakiTeruaki Tozaki
Teruaki Tozaki
AOAoi Ohnuma
Aoi Ohnuma
NHNatasha Hamilton
Natasha Hamilton
MKMIO KIKUCHI
MIO KIKUCHI
TITaichiro Ishige
Taichiro Ishige
SNShun‐Ichi Nagata
Shun‐Ichi Nagata

16 July 2021 in Drug Testing and Analysis
Verified
Journal Article
Closed access
PDF file
Teruaki TozakiTeruaki Tozaki
Teruaki Tozaki
AOAoi Ohnuma
Aoi Ohnuma
MKMio Kikuchi
Mio Kikuchi
TITaichiro Ishige
Taichiro Ishige
HKHironaga Kakoi
Hironaga Kakoi
SNShun‐Ichi Nagata
Shun‐Ichi Nagata